Characterization of a Modified Clinical Linear Accelerator for Ultra-High Dose Rate Beam Delivery
-
Published:2024-08-27
Issue:17
Volume:14
Page:7582
-
ISSN:2076-3417
-
Container-title:Applied Sciences
-
language:en
-
Short-container-title:Applied Sciences
Author:
Deut Umberto12ORCID, Camperi Aurora2, Cavicchi Cristiano3, Cirio Roberto12ORCID, Data Emanuele Maria12ORCID, Durisi Elisabetta Alessandra12ORCID, Ferrero Veronica12, Ferro Arianna12, Giordanengo Simona2, Villarreal Oscar Martì4ORCID, Mas Milian Felix125ORCID, Medina Elisabetta12ORCID, Olivares Diango M. Montalvan12, Mostardi Franco12, Monti Valeria12ORCID, Sacchi Roberto12ORCID, Salmeri Edoardo3ORCID, Vignati Anna12ORCID
Affiliation:
1. Department of Physics, University of Turin, 10125 Turin, Italy 2. Section of Turin, National Institute of Nuclear Physics (INFN), 10125 Turin, Italy 3. Elekta S.p.A., 20864 Agrate Brianza, Italy 4. Center for Sensors and Devices, Bruno Kessler Foundation (FBK), 38122 Trento, Italy 5. Department of Exact and Technological Sciences, Universidade Estadual de Santa Cruz, Ilhéus 45662-900, Brazil
Abstract
Irradiations at Ultra-High Dose Rate (UHDR) regimes, exceeding 40 Gy/s in single fractions lasting less than 200 ms, have shown an equivalent antitumor effect compared to conventional radiotherapy with reduced harm to normal tissues. This work details the hardware and software modifications implemented to deliver 10 MeV UHDR electron beams with a linear accelerator Elekta SL 18 MV and the beam characteristics obtained. GafChromic EBT XD films and an Advanced Markus chamber were used for dosimetry characterization, while a silicon sensor assessed the machine’s beam pulses stability and repeatability. The dose per pulse, average dose rate and instantaneous dose rate in the pulse were evaluated for four experimental settings, varying the source-to-surface distance and the beam collimation, i.e., with and without the use of a cylindrical applicator. The results showed a dose per pulse from 0.6 Gy to a few tens of Gy and an average dose rate up to 300 Gy/s. The obtained results demonstrate the possibility to perform in vitro radiobiology experiments and test new technologies for beam monitoring and dosimetry at the upgraded LINAC, thus contributing to the electron UHDR research field.
Funder
National Institute for Nuclear Physics National Institute for Nuclear Physics (INFN), CSN5 Call 2021, project “FRIDA” Compagnia di San Paolo CRT Foundationgrant
Reference27 articles.
1. Ultrahigh dose-rate FLASH irradiation increases the differential response between normal and tumor tissue in mice;Favaudon;Sci. Transl. Med.,2014 2. Irradiation in a Flash: Unique Sparing of Memory in Mice after Whole Brain Irradiation with Dose Rates above 100 Gy/s;Petersson;Radiother. Oncol.,2017 3. The Advantage of FLASH Radiotherapy Confirmed in Mini-pig and Cat-cancer Patients;Vozenin;Clin. Cancer Res.,2019 4. Hageman, E., Che, P.-P., Dahele, M., Slotman, B.J., and Sminia, P. (2022). Radiobiological Aspects of FLASH Radiotherapy. Biomolecules, 12. 5. Di Martino, F., Barca, P., Barone, S., Bortoli, E., Borgheresi, R., De Stefano, S., Di Francesco, M., Faillace, L., Giuliano, L., and Grasso, L. (2020). FLASH Radiotherapy With Electrons: Issues Related to the Production, Monitoring, and Dosimetric Characterization of the Beam. Front. Phys., 8.
|
|